NASDAQ: AVXL ANAVEX LIFE SCIENCES CORP. 8-K

Anavex withdraws EU marketing application for Alzheimer's drug blarcamesine

Filed March 25, 2026 · Period ending March 25, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade AVXL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 4:50 AM